WHO approves China's Sinopharm vaccine for emergency use

A medical worker prepares vials of the COVID-19 vaccines, Chinese Sinopharm, left, Sputnik V, center, and Pfizer at a vaccine centre, in the Usce shopping mall in Belgrade.
A medical worker prepares vials of the COVID-19 vaccines, Chinese Sinopharm, left, Sputnik V, center, and Pfizer at a vaccine centre, in the Usce shopping mall in Belgrade. Copyright Darko Vojinovic/Copyright 2021 The Associated Press. All rights reserved.
By Euronews
Share this articleComments
Share this articleClose Button
Copy/paste the article video embed link below:Copy to clipboardCopied

Sinopharm can now be used and distributed as part of the COVAX mechanism.

ADVERTISEMENT

The World Health Organization has given the green light to the Sinopharm COVID-19 vaccine, paving the way for use of the Chinese-made worldwide.

Created by the Beijing Bio-Institute of Biological Products Company, a subsidiary of China National Biotec Group (CNBG), Sinopharm can now be distributed as part of COVAX, the UN-led mechanism that provides COVID-19 vaccines to countries in the developing world.

“The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk,” said Mariângela Simão, WHO assistant-director general for access to health products, in a press release on Friday.

“We urge the manufacturer to participate in the COVAX Facility and contribute to the goal of more equitable vaccine distribution.”

WHO's emergency listing was given to Sinopharm after inspections of its manufacturing facilities. It estimates that Siopharm is 79% effective against coronavirus.

WHO has also listed the Pfizer/BioNTech, AstraZeneca, Johnson & Johnson, and Moderna vaccines for emergency use.

Sinopharm is already in wide use in Europe, including in Serbia - where it is produced - and Hungary.

Share this articleComments

You might also like

Serbia to produce Chinese COVID-19 vaccine

Hungary's PM Viktor Orbán vaccinated against COVID with Chinese Sinopharm vaccine

Serbia has second fastest COVID-19 vaccine rollout in Europe thanks to China